<DOC>
	<DOCNO>NCT00141154</DOCNO>
	<brief_summary>To verify superiority celecoxib ( YM177 ) 200 mg bid placebo treatment patient low back pain well non-inferiority loxoprofen sodium 60 mg tid .</brief_summary>
	<brief_title>Comparison Of Celecoxib 200 Mg Bid , Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients major site low back pain 12th thoracic vertebra low Patients low back pain least two week Patients previous history complication rheumatoid arthritis , spondylarthrosis negative serum reaction ( ankylose spondylarthritis , psoriatic arthritis ) , metastasis tumor , Paget 's disease , fibromyalgia , tumor infection spinal cord intervertebral disc , disease cause systemic pain</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>